Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2
Mol Cell
.
2021 Jan 7;81(1):212.
doi: 10.1016/j.molcel.2020.12.028.
Authors
Ryan M Hekman
,
Adam J Hume
,
Raghuveera Kumar Goel
,
Kristine M Abo
,
Jessie Huang
,
Benjamin C Blum
,
Rhiannon B Werder
,
Ellen L Suder
,
Indranil Paul
,
Sadhna Phanse
,
Ahmed Youssef
,
Konstantinos D Alysandratos
,
Dzmitry Padhorny
,
Sandeep Ojha
,
Alexandra Mora-Martin
,
Dmitry Kretov
,
Peter E A Ash
,
Mamta Verma
,
Jian Zhao
,
J J Patten
,
Carlos Villacorta-Martin
,
Dante Bolzan
,
Carlos Perea-Resa
,
Esther Bullitt
,
Anne Hinds
,
Andrew Tilston-Lunel
,
Xaralabos Varelas
,
Shaghayegh Farhangmehr
,
Ulrich Braunschweig
,
Julian H Kwan
,
Mark McComb
,
Avik Basu
,
Mohsan Saeed
,
Valentina Perissi
,
Eric J Burks
,
Matthew D Layne
,
John H Connor
,
Robert Davey
,
Ji-Xin Cheng
,
Benjamin L Wolozin
,
Benjamin J Blencowe
,
Stefan Wuchty
,
Shawn M Lyons
,
Dima Kozakov
,
Daniel Cifuentes
,
Michael Blower
,
Darrell N Kotton
,
Andrew A Wilson
,
Elke Mühlberger
,
Andrew Emili
PMID:
33417854
PMCID:
PMC7831449
DOI:
10.1016/j.molcel.2020.12.028
No abstract available
Publication types
Published Erratum
Grants and funding
R00 GM124458/GM/NIGMS NIH HHS/United States
R01 HL095993/HL/NHLBI NIH HHS/United States
RF1 AG056318/AG/NIA NIH HHS/United States
R01 HS018414/HS/AHRQ HHS/United States
RF1 AG061706/AG/NIA NIH HHS/United States
R01 AG064932/AG/NIA NIH HHS/United States
T32 HL007035/HL/NHLBI NIH HHS/United States